Ji Zhiyong, Ling Yeping, Chen Pingbo, Meng Yuxiao, Xu Shancai, Wu Pei, Wang Chunlei, Ilyasova Tatiana, Sun Bowen, Shi Huaizhang
Department of Neurosurgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Department of Internal Diseases, Bashkir State Medical University, Ufa, Russian Federation.
Front Surg. 2023 Jan 6;9:1074514. doi: 10.3389/fsurg.2022.1074514. eCollection 2022.
The management of patients with symptomatic non-acute atherosclerotic intracranial artery occlusion (sNAA-ICAO), which is a special subset with high morbidity and a high probability of recurrent serious ischemic events despite standard medical therapy, has been clinically challenging. A number of small-sample clinical studies have discussed endovascular recanalization for sNAA-ICAO and the lack of a uniform standard of operation time. The purpose of this study was to investigate the time correlation of successful recanalization.
From January 2013 to August 2021, 69 consecutive patients who underwent endovascular recanalization for sNAA-ICAO were analyzed retrospectively in the First Affiliated Hospital of Harbin Medical University. The technical success rate, periprocedural complications, and rate of TIA/ischemic stroke during follow-up were evaluated.
The overall technical success rate was 73.91% (51/69), and the rate of perioperative complications was 37.68% (26/69). The percentage of patients with perioperative symptoms was 27.53% (19/69). The rate of serious symptomatic perioperative complications was 8.70% (6/69). After adjusting for age, sex, and BMI, the effect of the time from the last symptom to operation on successful recanalization was 0.42 (IQR, 0.20, 0.88, = 0.021), before the inflection point (51 days).
Endovascular recanalization for sNAA-ICAO is technically feasible in reasonably selected patients. The perioperative safety is within the acceptable range. Before 51 days, the last symptoms to operation time, for every 10 days of delay, the probability of successful recanalization is reduced by 57%.
有症状的非急性动脉粥样硬化性颅内动脉闭塞(sNAA - ICAO)患者的管理具有临床挑战性,这类患者是一个特殊亚组,尽管接受了标准药物治疗,但发病率高且复发严重缺血事件的可能性大。一些小样本临床研究讨论了sNAA - ICAO的血管内再通以及缺乏统一的手术时间标准。本研究的目的是探讨成功再通的时间相关性。
回顾性分析2013年1月至2021年8月在哈尔滨医科大学附属第一医院连续接受sNAA - ICAO血管内再通治疗的69例患者。评估技术成功率、围手术期并发症以及随访期间短暂性脑缺血发作/缺血性卒中的发生率。
总体技术成功率为73.91%(51/69),围手术期并发症发生率为37.68%(26/69)。围手术期有症状患者的比例为27.53%(19/69)。围手术期严重有症状并发症的发生率为8.70%(6/69)。在调整年龄、性别和体重指数后,从最后症状出现到手术的时间对成功再通的影响为0.42(四分位间距,0.20,0.88,P = 0.021),在拐点(51天)之前。
对于合理选择的患者,sNAA - ICAO的血管内再通在技术上是可行的。围手术期安全性在可接受范围内。在51天之前,即从最后症状出现到手术的时间,每延迟10天,成功再通的概率降低57%。